Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Kidney and hypertension.

Marcin Adamczak1, Martin Zeier, Ralf Dikow

  • 1Department of Internal Medicine, Ruperto Carola University, Heidelberg, Germany.

Kidney International. Supplement
|May 2, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The evolving field of nephrology: what comes next? A report from the European Renal Association Scientific Advisory Board.

Clinical kidney journal·2026
Same author

Intestinal microbiome and acute transplanted kidney rejection - results of a single-center, case-control study.

BMC nephrology·2026
Same author

Patient Education in Chronic Kidney Disease: A Position Statement of the Polish Society of Nephrology.

International journal of nephrology and renovascular disease·2026
Same author

Randomized controlled trials in Europe: a call to action to protect national healthcare systems from the upcoming tsunami of kidney failure.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association·2026
Same author

Gut microbiota and arterial hypertension: a narrative review.

Archives of medical science : AMS·2025
Same author

Zilebesiran-Small Interfering RNAs as Prospective New Drug in the Treatment of Hypertension.

Journal of clinical medicine·2025
Same journal

Effect of kidney disease on glucose handling (including genetic defects).

Kidney international. Supplement·2011
Same journal

Need for better diabetes treatment for improved renal outcome.

Kidney international. Supplement·2011
Same journal

Glucose dynamics and mechanistic implications of SGLT2 inhibitors in animals and humans.

Kidney international. Supplement·2011
Same journal

SGLT2 inhibitors: molecular design and potential differences in effect.

Kidney international. Supplement·2011
Same journal

Glucose handling by the kidney.

Kidney international. Supplement·2011
Same journal

Bone: from a reservoir of minerals to a regulator of energy metabolism.

Kidney international. Supplement·2011
See all related articles

Kidney disease increases blood pressure (BP), while high BP damages kidneys. Treatments targeting the renin-angiotensin system (RAS) and sympathetic nerve system offer kidney protection independent of BP reduction.

Area of Science:

  • Nephrology
  • Cardiovascular Medicine
  • Hypertension Research

Background:

  • The kidney and blood pressure (BP) share a bidirectional relationship, where renal dysfunction elevates BP, and hypertension accelerates kidney damage.
  • Transplantation studies demonstrate that kidney function influences BP, with donor kidney genetics impacting recipient BP levels.
  • Family studies reveal a higher prevalence of hypertension in relatives of individuals with primary glomerulonephritis or diabetic nephropathy.

Purpose of the Study:

  • To elucidate the intricate relationship between kidney function and blood pressure regulation.
  • To review evidence supporting the detrimental effects of hypertension on renal function.
  • To summarize the mechanisms driving BP elevation in renal disease and the renoprotective effects of specific pharmacological interventions.

Related Experiment Videos

Main Methods:

  • Review of transplantation studies in animals and humans.
  • Analysis of family studies on hypertension prevalence in relatives of patients with kidney disease.
  • Examination of observational and interventional trial data (e.g., AIPRI, REIN, IDNT, RENAAL) on renal disease and hypertension.
  • Investigation of pharmacological interventions targeting the renin-angiotensin system (RAS) and sympathetic nerve system.

Main Results:

  • Transplantation studies confirm that "blood pressure follows the kidney."
  • Hypertension is shown to accelerate the loss of renal function, challenging previous beliefs.
  • Mechanisms of BP increase in renal disease include salt retention, activated RAS and sympathetic nerve system, and impaired vasodilation.
  • Pharmacological blockade of the RAS and sympathetic nerve system demonstrates BP-independent renoprotective effects, reducing albuminuria and glomerulosclerosis.

Conclusions:

  • The kidney-blood pressure axis is complex, with mutual influence and reinforcement.
  • Targeting the RAS and sympathetic nerve system offers significant renoprotection, extending beyond BP control.
  • Understanding these mechanisms is crucial for managing hypertensive kidney disease and preventing further renal decline.